Skip to content

The Evaluation of Single Acupoint Therapy to Acute Low Back Pain

The Evaluation of Single Acupoint Therapy to Acute Low Back Pain

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04328428
Enrollment
90
Registered
2020-03-31
Start date
2020-03-28
Completion date
2021-02-12
Last updated
2020-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acupuncture, Acute Low Back Pain

Keywords

acute low back pain, BL40, Extra Meridian 32 (EM32), acupuncture

Brief summary

Low back pain is the leading course of disability , affecting patients' health and work. Recently, studies have reveal the fact that patients get insufficient physical activity and easily let acute stage turn to chronic type. Although acupuncture for low back pain is worldwide popular, the mechanism of single acupoint for low back pain is still unclear. Therefore, the aim of this study is the investigators choose the most frequent used acupoint and modified single acupoint method to assess the efficacy of single acupoint to acute low back pain.

Detailed description

Low back pain is the leading course of disability , affecting patients' health and work. According to the study in 2013, 8.9 percent people of the world experienced over three months low back pain. Recently, studies have reveal the fact that patients get insufficient physical activity and easily let acute stage turn to chronic type. Although acupuncture for low back pain is worldwide popular, the mechanism of single acupoint for low back pian is still unclear. Therefore, the investigators choose the most frequent used acupoint and modified single acupoint method to assess the efficacy of single acupoint to acute low back pain. The investigators would like to compare the efficacy of the modified Bladder 40 (BL40) acupuncture to single acupoint through statistical analysis. The investigators expect that all group will alleviate low back pain. However, treatment group will have statistical difference compared with control groups. The aim of this study is the investigators choose the most frequent used acupoint and modified single acupoint method to assess the efficacy of single acupoint to acute low back pain.

Interventions

OTHERacupuncture

Use one acupuncture needle insert in a acupoint.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

The participants only know that they accept acupuncture ,but do not know which acupoint needling they receive.

Intervention model description

three groups randomly:experiment group and two control groups. Patients in experiment group receive modified BL40 acupuncture. Control group one receives EM32 acupuncture and control group two receives BL40 acupuncture

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* low back pain,duration \< 1 month * accept subject consent

Exclusion criteria

* without X ray or MRI image * severe trauma , fracture or spondylosis found from image ,progression neurological symptoms suspected from central nerve system, rheumatic disease, fever or infection is suspected ,weight or cancer history , pregnancy and psychiatric disorder or not able to communication .

Design outcomes

Primary

MeasureTime frameDescription
pain measurement30 minutesuse Visual Analogue Scale to measure pain intensity and algometer to measure pain threshold The minimum of Visual Analogue Scale is 0 and maximum values is 10. The higher Visual Analogue Scale mean a worse outcome . Newton is used to measure pain threshold. The higher pain threshold scores mean a better outcome .
range of motion measurement30 minutesmeasure the range of motion when lumbar extension and flexion

Countries

Taiwan

Contacts

Primary ContactYuan-Xin Lai, MD
u9802401@cmu.edu.tw+886-3-3196200
Backup ContactKo-Hung Lee, MD
greglgc@cgmh.org.tw+886-3-3196200

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026